Sas-Korczynska Beata, Reinfuss Marian, Mitus Jerzy W, Pluta Elzbieta, Patla Anna, Walasek Tomasz
Clinic of Oncology, Maria Sklodowska-Curie Institute - Oncology Center, Krakow Branch, Poland.
Department of Radiotherapy, Maria Sklodowska-Curie Institute - Oncology Center, Krakow Branch, Poland.
Rep Pract Oncol Radiother. 2018 Sep-Oct;23(5):402-406. doi: 10.1016/j.rpor.2018.07.014. Epub 2018 Aug 17.
Radiotherapy in patients with sinonasal mucosal melanoma (SNMM) was given as alternative treatment to surgery in cases with advanced, inoperable tumors or those not eligible for surgery. We presented the outcomes for patients with SNMM treated with radiotherapy alone.
The retrospective review of 6 consecutive SNMM (nasal cavity - 4 pts. and paranasal sinus - 2 pts.) patients (3 males and 3 females at mean age 64 years) treated between 2008 and 2016 was presented. The stage of disease was: T3 (1 pt.), T4a (3 pts.), T4b (2 pts.); with N0 and M0 in all patients. All patients underwent definitive primary photon radiotherapy (IMRT) alone; dose 66-72 Gy was delivered in 22-24 fractions given in 5 fractions (3 Gy) a week.
The complete remission was observed in all our patients but only one patient survived 5 years without disease. Five patients died due to multiple distant metastases; two of those patients developed associated local recurrence 7-8 months after radiotherapy.
SNMM has a poor prognosis due to its high metastatic potential. Based on our numerically small report and data from literature we concluded that primary radiotherapy alone assured complete remission and even 5-year disease-free survival in only a few individual patients.
对于鼻窦黏膜黑色素瘤(SNMM)患者,放疗作为晚期、无法手术或不符合手术条件肿瘤患者手术的替代治疗方法。我们展示了仅接受放疗的SNMM患者的治疗结果。
回顾性分析了2008年至2016年间连续收治的6例SNMM患者(鼻腔4例,鼻窦2例)(3例男性,3例女性,平均年龄64岁)。疾病分期为:T3(1例),T4a(3例),T4b(2例);所有患者均为N0和M0。所有患者均仅接受了根治性原发性光子放疗(调强放疗);剂量为66 - 72 Gy,分22 - 24次给予,每周5次(每次3 Gy)。
我们所有患者均观察到完全缓解,但只有1例患者无病生存5年。5例患者死于多处远处转移;其中2例患者在放疗后7 - 8个月出现局部复发。
由于SNMM具有高转移潜能,其预后较差。基于我们数量较少的报告及文献数据,我们得出结论,单纯原发性放疗仅能使少数个体患者实现完全缓解甚至5年无病生存。